Pharmacological attenuation of myocardial reperfusion injury in a closed-chest porcine model: A systematic review

Journal of Cardiovascular Translational Research

Volumn 7, Issue 6, 2014, Pages 570-580

  Ekeløf, Sarah ^a   Rosenberg, Jacob ^a   Jensen, Jan Skov ^a   Gögenur, Ismail ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Acute myocardial infarction; Experimental model; Ischemia reperfusion injury; Pharmacology

Indexed keywords

ADC 1004; ANESTHETIC AGENT; APOSEC; BRADYKININ; CAPTOPRIL; CARDIOVASCULAR AGENT; CLEVIDIPINE; COMPLEMENT INHIBITOR; COPPER ZINC SUPEROXIDE DISMUTASE; CYCLOSPORIN A; DEXTRAN SULFATE; ERIBIS PEPTIDE 94; GRANULOCYTE COLONY STIMULATING FACTOR; HALOTHANE; ISOFLURANE; MICRORNA; MICRORNA 92A; MIDKINE; MIROCEPT; NITROUS OXIDE; PENTOBARBITAL; PERINDOPRILAT; PLACEBO; PROTEIN KINASE C GAMMA; RECOMBINANT HUMAN FOLLISTATIN LIKE 1 PROTEIN; SALVIANOLATE; SEVOFLURANE; SODIUM CHLORIDE; SULFOTYROSINE POLYACRYLAMIDE CONJUGATE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIOXIDANT ACTIVITY; BALLOON CATHETER; CHEMOPROPHYLAXIS; DRUG EFFECT; DRUG MECHANISM; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; INDUCED HYPOTHERMIA; ISCHEMIC POSTCONDITIONING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SWINE; SYSTEMATIC REVIEW; ANIMAL; DISEASE MODEL; MYOCARDIAL REPERFUSION INJURY; PIG; TREATMENT OUTCOME;

SUS;

ANIMALS; CARDIOVASCULAR AGENTS; DISEASE MODELS, ANIMAL; MYOCARDIAL REPERFUSION INJURY; SWINE; TREATMENT OUTCOME;

EID: 84906790793     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-014-9574-4     Document Type: Review

References (64)

1. Yellon, D. M., & Hausenloy, D. J. (2007). Myocardial reperfusion injury. New England Journal of Medicine, 357, 1121-1135.
2. Verma, S., Fedak, P.W., Weisel, R. D., et al. (2002). Fundamentals of reperfusion injury for the clinical cardiologist. Circulation, 105, 2332-2336. (Pubitemid 34556381)
3. Gross, E. R., & Gross, G. J. (2007). Pharmacologic therapeutics for cardiac reperfusion injury. Expert Opinion on Emerging Drugs, 12, 367-388. (Pubitemid 47518374)
4. Armstrong, P. W., Granger, C. B., Adams, P. X., et al. (2007). Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. JAMA, 297, 43-51. (Pubitemid 46041725)
5. Bates, E., Bode, C., Costa, M., et al. (2008). Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Direct inhibition of delta-protein kinase c enzyme to limit total infarct size in acute myocardial infarction. Circulation, 117, 886-896. (Pubitemid 351272586)
6. Piot, C., Croisille, P., Staat, P., et al. (2008). Effect of cyclosporine on reperfusion in acute myocardial infarction. New England Journal of Medicine, 359, 473-481.
7. Flaherty, J. T., Pitt, B., Gruber, J. W., et al. (1994). Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction. Circulation, 89, 1982-1991. (Pubitemid 24142772)
8. Pérez de Prado, A., Cuellas-Ramón, C., Regueiro- Purriños, M., et al. (2009). Closed-chest experimental porcine model of acute myocardial infarction-reperfusion. Journal of Pharmacological and Toxicological Methods, 60, 301-306.
9. Suzuki, Y., Lyons, J. K., Yeung, A. C., et al. (2008). In vivo porcine model of reperfused myocardial infarction: in situ double staining to measure precise infarct area/area at risk. Catheterization and Cardiovascular Interventions, 71, 100-107. (Pubitemid 351158353)
10. Krombach, G. A., Kinzel, S., Mahnken, A. H., et al. (2005). Minimally invasive close-chest method for creating reperfused or occlusive myocardial infarction in swine. Investigative Radiology, 40, 14-18. (Pubitemid 40029889)
11. Busch, S., Halladin, N. L., Jensen, S. E., Rosenberg, J., et al. (2012). Closed-chest porcine model is superior in intervention studies of ischaemia reperfusion injury. Ugeskrift for Laeger, 174, 1807-1810.
12. Rentoukas, I., Giannopoulos, G., Kaoukis, A., et al. (2010). Cardioprotective role of remote ischemic periconditioning in primary percutaneous coronary intervention. JACC Cardiovascular Interventions, 3, 49-55.
13. Liberati, A., Altman, D. G., Tetzlaff, J., et al. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Annals of Internal Medicine, 151, W65-W94.
14. van der Pals, J., Koul, S., Andersson, P., et al. (2010). Treatment with the C5a receptor antagonistADC-1004 reducesmyocardial infarction in the porcine ischemia-reperfusion model. BMC Cardiovascular Disorders, 10, 45.
15. Banz, Y., Hess, O. M., Robson, S. C., et al. (2007). Attenuation of myocardial reperfusion injury in pigs by Mirocept, a membranetargeted complement inhibitor derived for human CR1. Cardiovascular Research, 76, 482-493. (Pubitemid 350007457)
16. Banz, Y., Hess, O. M., Robson, S. C., et al. (2005). Locally targeted cytoprotection with dextran sulfate attenuates experimental porcine myocardial ischemia/reperfusion injury. European Heart Journal, 26, 2334-2343. (Pubitemid 41541401)
17. Banz, Y., Hess, O. M., Meier, P., et al. (2012). Evaluation of multimeric tyrosine-o-sulfate as a cytoprotectant in an in vivo model of acute myocardial infarction in pigs. Cardiology, 121, 59-70.
18. Inagaki, K., Chen, L., Ikeno, F., et al. (2003). Inhibition of delta-protein kinase c protects against reperfusion injury of the ischemic heart in vivo. Circulation, 108, 2304-2307. (Pubitemid 37413533)
19. Ishiguro, H., Horiba, M., Takenaka, H., et al. (2011). A single intracoronary injection of midkine reduces ischemia/reperfusion injury in swine hearts: a novel therapeutic approach for acute coronary syndrome. Frontiers in Physiology, 2, 27.
20. Angeli, F. S., Smith, C., Amabile, N., et al. (2010). Granulocyte colony stimulating factor in myocardial infarction with low ejection fraction. Cytokine, 51, 278-285.
21. Karlsson, L. O., Bergh, N., & Grip, L. (2012). Cyclosporine a, 2, 5 mg/kg, does not reduce myocardial infarct size in a porcine model of ischemia and reperfusion. Journal of Cardiovascular Pharmacology and Therapeutics, 17, 159-163.
22. Karlsson, L. O., Grip, L., Bissessar, E., et al. (2011). Opioid receptor agonist Eribis peptide 94 reduces infarct size in different porcine models for myocardial ischaemia and reperfusion. European Journal of Pharmacology, 651, 146-151.
23. Odenstedt, J., Mansson, C.,& Grip, L. (2004). Failure to demonstrate myocardial protective effects of the ultra short-acting calcium antagonist clevidipine in a closed-chest reperfusion porcine model. Journal of Cardiovascular Pharmacology, 44, 407-415. (Pubitemid 39305081)
24. Han, B., Zhang, X., Zhang, Q., et al. (2011). Protective effects of salvianolate on microvascular flow in a porcine model of myocardial ischaemia and reperfusion. Archives of Cardiovascular Diseases, 104, 313-324.
25. Näslund, U., Häggmark, S., Johansson, G., et al. (1990). Limitation of myocardial infarct size by superoxide dismutase as an adjunct to reperfusion after different durations of coronary occlusion in the pig. Circulation Research, 66, 1294-1301. (Pubitemid 20147746)
26. Näslund, U., Häggmark, S., Johansson, G., et al. (1992). Effects of reperfusion and superoxide dismutase on myocardial infarct size in a closed chest pig model. Cardiovascular Research, 26, 170-178.
27. Lichtenauer, M., Mildner, M., Hoetzenecker, K., et al. (2011). Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodeling after acute myocardial infarction: a preclinical study. Basic Research in Cardiology, 106, 1283-1297.
28. Tio, R. A., Tobé, T. J., Bel, K. J., et al. (1991). Beneficial effects of bradykinin on porcine ischemic myocardium. Basic Research in Cardiology, 86, 107-116.
29. Van Wijngaarden, J., Tobé, T. J., Weersink, E. G., et al. (1992). Effects of early angiotensin-converting enzyme inhibition in a pig model of myocardial ischemia and reperfusion. Journal of Cardiovascular Pharmacology, 19, 408-416.
30. DeGraeff, P. A., de Langen, C. D., van Gilst, W. H., et al. (1988). Protective effects of captopril against ischemia/reperfusion-induced ventricular arrhythmias in vitro and in vivo. American Journal of Medicine, 84, 67-74.
31. Thornell, L. E., Holmbom, B., Eriksson, A., et al. (1992). Enzyme and immunohistochemical assessment of myocardial damage after ischaemia and reperfusion in a closed-chest pig model. Histochemistry, 98, 341-352.
32. Downey, J. M., Davis, A. M., & Cohen, M. V. (2007). Signaling pathways in ischemic preconditioning. Heart Failure Reviews, 12, 181-188. (Pubitemid 350176691)
33. Baxter, G. F., & Ebrahim, Z. (2002). Role of bradykinin in preconditioning and protection of the ischaemic myocardium. British Journal of Pharmacology, 135, 843-854. (Pubitemid 34214443)
34. Correa, F., Martínez-Abundis, E., Hernández- Reséndiz, S., et al. (2010). Pharmacological strategies to contend against myocardial reperfusion damage: diverse chemicals for multiple targets. Current Medicinal Chemistry, 17, 2261-2273.
35. Wang, L. X., Ideishi, M., Yahiro, E., et al. (2001). Mechanism of the cardioprotective effect of inhibition of the rennin-angiotensin system on ischemia/reperfusion-induced myocardial injury. Hypertension Research, 24, 179-187. (Pubitemid 32377590)
36. Manolis, A. J., Marketou, M. E., Gavras, I., et al. (2010). Cardioprotective properties of bradykinin: role of the B(2) receptor. Hypertension Research, 33, 772-777.
37. Ma, X. J., Yin, H. J., Guo, C. Y., et al. (2012). Ischemic postconditioning through percutaneous transluminal coronary angioplasty in pigs: roles of PI3K activation. Coronary Artery Disease, 23, 245-250.
38. Otaka, H., Shite, J., Paredes, O. L., et al. (2007). Catheter-based transcoronary myocardial hypothermia attenuates arrhythmia and myocardial necrosis in pigs with acute myocardial infarction. Journal of the American College of Cardiology, 49, 250-260. (Pubitemid 46054394)
39. Hinkel, R., Penzkofer, D., Zühlke, S., et al. (2013). Inhibition of MicroRNA-92a protects against ischemia/reperfusion injury in a large-animal model. Circulation, 128, 1066-1075.
40. Ogura, Y., Ouchi, N., Ohashi, K., et al. (2012). Therapeutic impact of follistatin-like 1 on myocardial ischemic injury in preclinical models. Circulation, 126, 1728-1738.
41. Grund, F., Sommerschild, H. T., Kirkeboen, K. A., et al. (1998). A new approach to normalize myocardial temperature in the open-chest model. Journal of Applied Physiology, 84, 2190-2197. (Pubitemid 28255984)
42. Kato, R., & Foëx, P. (2002). Myocardial protection by anaesthetic agents against ischemia-reperfusion injury: an update for anesthesiologists. Canadian Journal of Anaesthesia, 49, 777-791.
43. Weber, N. C., Preckel, B., & Schlack, W. (2005). The effect of anaesthetics on the myocardium-new insights into myocardial protection. European Journal of Anaesthesiology, 22, 647-657. (Pubitemid 41297546)
44. Ross, S., & Foëx, P. (1999). Protective effects of anaesthetics in reversible and irreversible ischaemia-reperfusion injury. British Journal of Anaesthesia, 82, 622-632.
45. Larsen, J. R., Aagaard, S., Lie, R. H., et al. (2008). Sevoflurane improves myocardial ischaemic tolerance in a closed-chest porcine model. Acta Anaesthesiologica Scandinavica, 52, 1400-1410.
46. Zaugg, M., Lucchinetti, E., Spahn, D. R., et al. (2002). Differential effects of anaesthetics on mitochondrial K(ATP) channel activity and cardiomyocyte protection. Anesthesiology, 97, 15-23. (Pubitemid 34733917)
47. Szekely, A., Heindl, B., Zahler, S., et al. (2000). Nonuniform behavior of intravenous anaesthetics on postischemic adhesion of neutrophils in the guinea pig heart. Anesthesia and Analgesia, 90, 1293-1300. (Pubitemid 30351326)
48. Kim, H. S., Hwang, K. C., & Park, W. K. (2010). Cardio protection via modulation of calcium homeostasis by thiopental in hypoxia-reoxygenated neonatal rat cardiomyocytes. Yonsei Medical Journal, 51, 187-196.
49. Garcia-Dorado, D., Théroux, P., Elizaga, J., et al. (1987). Myocardial reperfusion in the pig heart model: infarct size and duration of coronary occlusion. Cardiovascular Research, 21, 537-544. (Pubitemid 17106456)
50. Klein, H. H., Schubothe, M., Nebendahl, K., et al. (1984). Temporal and spatial development of infarcts in porcine hearts. Basic Research in Cardiology, 79, 440-447. (Pubitemid 14053181)
51. Reimer, K. A., Vander Heide, R. S., & Richard, V. J. (1993). Reperfusion in acute myocardial infarction: effect of timing and modulating factors in experimental models. American Journal of Cardiology, 72, 13G-21G. (Pubitemid 24023481)
52. Vivaldi, M. T., Kloner, R. A., & Schoen, F. J. (1985). Triphenyltetrazolium staining of irreversible ischemic injury following coronary artery occlusion in rats. American Journal of Pathology, 121, 522-530. (Pubitemid 16183372)
53. Rochitte, C. E., Lima, J. A., Bluemke, D. A., et al. (1998). Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. Circulation, 98, 1006-1014. (Pubitemid 28446654)
54. Arai, A. E. (2011). Magnetic resonance imaging for area at risk, myocardial infarction, and myocardial salvage. Journal of Cardiovascular Pharmacology and Therapeutics, 16, 313-320.
55. Kim, R. J., Fieno, D. S., Parrish, T. B., et al. (1999). Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation, 100, 1992-2002. (Pubitemid 29529292)
56. Gibbons, R. J. (2011). Tc-99m SPECTsestamibi for the measurement of infarct size. Pharmacology and Therapeutics, 16, 321-331.
57. Ahmed, N., Carrick, D., Layland, J., et al. (2013). The role of cardiac magnetic resonance imaging (MRI) in acute myocardial infarction (AMI). Heart, Lung & Circulation, 22, 243-255.
58. Ubachs, J. F., Engblom, H., Koul, S., et al. (2013). Myocardium at risk can be determined by ex vivo T2-weighted magnetic resonance imaging even in the presence of gadolinium: comparison to myocardial perfusion single photon emission computed tomography. European Heart Journal - Cardiovascular Imaging, 14, 261-268.
59. Koudstaal, S., Jansen of Lorkeers, S., Gho, J. M., et al. (2014). Myocardial Infarction and functional outcome assessment in pigs. Journal of Visualized Experiments. doi:10.3791/51269.
60. Chen, C. H., Chang, M. Y., Wang, S. S., et al. (2014). Injection of autologous bone marrow cells in hyaluronan hydrogel improves cardiac performance after infarction in pigs. American Journal of Physiology - Heart and Circulatory Physiology, 306, H1078 -H1086.
61. PROTECTION AMI Investigators. (2014). Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI randomized controlled trial. European Heart Journal. doi:10.1093/eurheartj/ehu177.
62. Kurz, T., Schäfer, U., Dendorfer, A., et al. (2001). Effects of intracoronary low-dose enalaprilat as an adjunct to primary percutaneous transluminal coronary angiography in acute myocardial infarction. American Journal of Cardiology, 88, 1351-1357. (Pubitemid 34008676)
63. Heusch, G. (2013). Cardioprotection: chances and challenges of its translation to the clinic. Lancet, 381, 166-175.
64. Miura, T., &Miki, T. (2008). Limitation of myocardial infarct size in the clinical setting: current status and challenges in translating animal experiments into clinical therapy. Basic Research in Cardiology, 103, 501-513.